Logo

Aurobindo Pharma Ltd. Share Price

Pharmaceuticals & Drugs

Aurobindo Pharma Ltd. (INR)1171.638.2   (3.4%)

Exchange ScripsBSE524804NSEAUROPHARMAISININE406A01037

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Aurobindo Pharma Ltd. Performance

Market performance

Open price1133.5
High1174
Volumes769623
Prev Close1171.6
Low1131.4
Closing date2025-04-17

Historical performance

1 Year High1592.00
3 Year High1592.00
5 Year High1592.00
1 Year Low1010.00
3 Year Low397.20
5 Year Low397.20

Aurobindo Pharma Ltd. Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
68047
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
21.63
Dividend Yield
Dividend Yield
0.38 %

Aurobindo Pharma Ltd. Investment Returns

1 Year
5.4%
3 Years
71.3%
5 Years
115.9%
10 Years
75.5%

Aurobindo Pharma Ltd. Technicals

IndicatorsValueSignal
5-DMA1116.03Bullish
10-DMA1121.08Bullish
20-DMA1145.35Bullish
50-DMA1132.92Bullish
100-DMA1183.77Bearish
200-DMA1307.8Bearish

Shareholding Pattern

FieldMar-2025Dec-2024Sep-2024Jun-2024Mar-2024
Promoters1414141414
Foreign Investors11111
Domestic Investors1313131313
Public Investors269309257948248474238608244561
Government11111

Aurobindo Pharma Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income5574290632263808
Operating Profit64004400924707157142
Interest28971405486745
Depreciation15217124461126510554
Profit Before Tax43800261253372773436
Consolidated Net Profit31730192752648253348
Adjusted EPS54334591

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital586586586586
Total Reserves297842267813245174218713
Minority Interest80120-19-9
Total Non-Current Liabilities18089866990318073
Total Liabilities438589392125336331334013
Capital Work in Progress27394449642937624289
Total Assets438589392125336331334013

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities24345238685016533290
Cash Flow from Investing Activities-42560-39778-321165987
Cash Flow from Financing Activitie800418144-29693-13649
Net Cash Inflow / Outflow-102102234-1164425628
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 21.63.
  • 3Y Stock Price CAGR of the stock is 20.2.
  • The stock has a beta of 0.8.
  • In the last financial year, the company had an EBITDA of ₹64004 Million.
  • The company generated revenue of ₹290019 Million in the previous financial year.

Aurobindo Pharma Ltd.

1171.638.2   (3.4%)

Investment Amount: ₹ 1000000
Current Value: ₹ 1088594.7
No. of Shares: 929.2
Performance:8.9%
P/L: ₹88594.7

Top Gainers

SymbolChange%
SECMARK124.29(20%)
OSWALGREEN43.33(18%)
FACT760.85(14%)
OSWALAGRO96.73(13%)
SMSLIFE1435.2(13%)

Top Losers

SymbolChange%
VIKASLIFE2.59(-9%)
ROML50.49(-7%)
ROSSELLIND77.66(-6%)
DYNPRO291(-6%)
SONATSOFTW314.7(-6%)
TREJHARA232.28(-6%)
GATECHDVR1.05(-5%)
MGEL14.23(-5%)

Similar stocks

Aarey Drugs & Pharmaceuticals Ltd.

65.8

56.06

March 20 - April 20

Brooks Laboratories Ltd.

41.3

139.77

March 20 - April 20

SMS Lifesciences India Ltd.

37.2

1435.2

March 20 - April 20

Panacea Biotec Ltd.

33.5

522.95

March 20 - April 20

Bal Pharma Ltd.

28.9

104.91

March 20 - April 20

Kopran Ltd.

27.8

202.58

March 20 - April 20

Wanbury Ltd.

27.2

263.47

March 20 - April 20

Hester Biosciences Ltd.

24.5

1774.9

March 20 - April 20

Announcing Stock of the Month!

Stock of the Month
Stock of the Month